Acute toxicity and dose constraints of organs at risk in Fast Forward radiotherapy in early stage breast cancer by Tomotherapy and Intensity-Modulated radiation therapy(IMRT)
Acute toxicity and dose constraints of organs at risk in Fast Forward radiotherapy in breast cancer by Tomotherapy and Intensity-Modulated radiation therapy(IMRT) in Omid hospital from 2026 to 2028
Design
Pragmatic Clinical trial with out a control group and single arm with out randomization and with out blinding.
Settings and conduct
Eligible patients in the radiotherapy department of Omid hospital with undergo breast radiotherapy with the IMRT technique using a Tomotherapy machine. The radiotherapy regimen used is based on the Fast Forward protocol and includes a dose of 26 Gy in 5 factions for the whole breast. Additionally for the patients who have an indication for a tumor bed boost, a boost dose of 9Gy in 3 fractions( 3 Gy per fraction daily) will be prescribed to the tumor bed.
Participants/Inclusion and exclusion criteria
inclusion criteria: Patients aged 18-70 years with primary breast cancer(T1-T2/N0/M0) treated with breast conserving surgery(who have received adjuvant and neoadjuvant endocrine therapy, chemotherapy, or immunotherapy).
exclusion criteria: History of previous radiotherapy to the chest or breast. History of skin or rheumatic diseases. Presence of a chest wall deformity that prevents radiotherapy planning. Use of drugs such as corticosteroids that affect skin response to radiotherapy. Non-completion in fallow up sessions, or withdrawal from the study.
Intervention groups
Eligible patients with undergo breast radiotherapy with the IMRT technique using a Tomotherapy machine based on the Fast Forward protocol and includes a dose of 26 Gy in 5 factions for the whole breast. A boost dose of 9Gy in 3 fractions will be prescribed to the tumor bed.
Main outcome variables
Dose constraints for organ at risk . including the heart, lungs, contralateral breast; radiotherapy complications including firmness and pain, skin erythema, cardiopulmonary complications, and lymphedema
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20261028071588N1
Registration date:2026-11-21, 1405/08/30
Registration timing:prospective
Last update:2026-11-21, 1405/08/30
Update count:0
Registration date
2026-11-21, 1405/08/30
Registrant information
Name
soheila seddighi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 51 3853 3388
Email address
soheila482s@gmail.com
Recruitment status
recruiting
Funding source
Expected recruitment start date
2026-11-22, 1405/09/01
Expected recruitment end date
2027-11-22, 1406/09/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Acute toxicity and dose constraints of organs at risk in Fast Forward radiotherapy in early stage breast cancer by Tomotherapy and Intensity-Modulated radiation therapy(IMRT)
Public title
Acute toxicity and dose constraints of organs at risk in Fast Forward radiotherapy in breast cancer
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Patients with primary breast cancer aged 18 to 70 years who are at stage T1-T2/N0/M0 and have undergone breast conserving surgery will be enrolled in the study. Patients who have received systemic therapies including endocrine therapy, chemotherapy, or immunotherapy in the adjuvant or neoadjuvant setting
Exclusion criteria:
Age
From 18 years old to 70 years old
Gender
Both
Phase
N/A
Groups that have been masked
No information
Sample size
Target sample size:
37
Randomization (investigator's opinion)
N/A
Randomization description
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Single
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Mashhad university of Medical Sciences
Street address
Koohsangi street. Alandasht square. Omid hospital
City
Mashhad
Province
Razavi Khorasan
Postal code
09176613775
Approval date
2026-10-28, 1405/08/06
Ethics committee reference number
IR.MUMS.IRH.REC.1405.167
Health conditions studied
1
Description of health condition studied
breast cancer in early stage(T1-T2/N0/M0) who underwent breast conserving surgery
ICD-10 code
C50
ICD-10 code description
Malignant neoplasm of breast
Primary outcomes
1
Description
Dose constraints for organs at risk including the heart, lungs and contralateral breast; Radiotherapy complications including firmness and pain, skin erythema, pain, cardiopulmonary complications and lymphedema.
Timepoint
Weekly visits during the radiotherapy course until one month; subsequent visits at months 3,6,12 and 18
Method of measurement
Acute and late radiotherapy complications will be assessed using the fallowing standard criteria: for comprehensive evaluation of complications CTCAE(Common Terminology Criteria for Adverse Events) and RTOG(Radiation Therapy Oncology group)/EORTC(European Organization for Research and Treatment of Cancer)for skin complications and radiations reactions. Complication assessment is performed in two ways: Clinician based : by a radiation oncologist during visits. Patient-reported(patient-based):Using validated questionnaires including skin symptoms, pain, edema, and cosmetic satisfaction
Secondary outcomes
1
Description
Evaluation of dose conformity to organ at risk(heart, lungs, contralateral breast
Timepoint
before start of radiotherapy of every patient
Method of measurement
based on Fast forward protocol
2
Description
Evaluation of the relationship between the received dose to organs at risk and the incidence of treatment related complications
Timepoint
at the end of 18 months fallow up
Method of measurement
based on Fast forward protocol
Intervention groups
1
Description
Intervention group: Breast cancer in early stage (T1-T2/N0/M0) who underwent breast conserving surgery
Category
Treatment - Other
Recruitment centers
1
Recruitment center
Name of recruitment center
Omid hospital
Full name of responsible person
Soudabeh Shahidsales
Street address
Koohsangi street. Alandasht square. Omid hospital
City
Mashhad
Province
Razavi Khorasan
Postal code
09176613775
Phone
+98 51 3842 6082
Email
omidhos@mums.ac.ir
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Mohsen Tafaghodi
Street address
ِDaneshgah Street. next to Hoveyzeh cinema. Mashhad University of Medical Sciences. Third floor. Vice Chancellor for Research and Technology
City
Mashhad
Province
Razavi Khorasan
Postal code
111111
Phone
+98 51 3841 1538
Email
TafaghodiM@mums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Mashhad University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Soheila Seddighi
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Radiotherapy
Street address
Koohsangi Street. Alandasht square. Omid hospital
City
Mashhad
Province
Razavi Khorasan
Postal code
09176613775
Phone
+98 51 3842 6082
Email
soheila482s@gmail.com
Person responsible for scientific inquiries
Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Seyyed Amir Aledavood
Position
Professor
Latest degree
Specialist
Other areas of specialty/work
Radiotherapy
Street address
Koohsangi Street. Alandasht square. Omid hospital
City
Mashhad
Province
Razavi Khorasan
Postal code
09176613775
Phone
+98 51 3842 6082
Email
aledavoodA@mums.ac.ir
Person responsible for updating data
Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Soheila Seddighi
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Radiotherapy
Street address
Koohsangi Street. Alandasht square. Omid hospital
City
Mashhad
Province
Razavi Khorasan
Postal code
09176613775
Phone
+98 51 3842 6082
Email
soheila482s@gmail.com
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Yes - There is a plan to make this available
Data Dictionary
Not applicable
Title and more details about the data/document
Information related to the primary outcome and primary and secondary variables and baseline data of study participants can be shared after de-identifying individuals
When the data will become available and for how long
start of the access period 6 months after the publication of the results
To whom data/document is available
Data will be accessible to both researcher working in academic and scientific institutions as well as individuals working in the industry
Under which criteria data/document could be used
Data will be available for scientific use and improving patients conditions.
From where data/document is obtainable
Via Email
What processes are involved for a request to access data/document
Initially the requester sends their request via email, and upon approval of the documents related to the individuals identity and their objectives for use of these data, the data will be made available to them.